BiotechTube

Solifenacin + Placebo

ApprovedTerminated
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pelvic Organ Prolapse

Conditions

Pelvic Organ Prolapse

Trial Timeline

Mar 1, 2010 → Oct 1, 2011

NCT ID
NCT01092624

About Solifenacin + Placebo

Solifenacin + Placebo is a approved stage product being developed by Astellas Pharma for Pelvic Organ Prolapse. The current trial status is terminated. This product is registered under clinical trial identifier NCT01092624. Target conditions include Pelvic Organ Prolapse.

What happened to similar drugs?

2 of 5 similar drugs in Pelvic Organ Prolapse were approved

Approved (2) Terminated (0) Active (3)
✅Conjugated Estrogens Cream + Placebo CreamPfizerApproved
✅Sevoflurane + propofol + remifentanilBaxterApproved
🔄AzithromycinPfizerPhase 3
🔄Ofloxacin + Avelox (Moxifloxacin, BAY12-8039)BayerPhase 3
🔄Moxifloxacin (Avelox, BAY12-8039) + Levofloxacin & MetronidazoleBayerPhase 3

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01092624ApprovedTerminated

Competing Products

11 competing products in Pelvic Organ Prolapse

See all competitors
ProductCompanyStageHype Score
BGS649 + PlaceboNovartisPhase 2
27
Tanezumab + PlaceboPfizerPhase 2
35
AzithromycinPfizerPhase 3
40
Vaginal estrogen + PlaceboPfizerPre-clinical
18
Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tabletPfizerPhase 2
27
Conjugated Estrogens Cream + Placebo CreamPfizerApproved
43
BAY1834845 + PlaceboBayerPhase 1
26
Ofloxacin + Avelox (Moxifloxacin, BAY12-8039)BayerPhase 3
37
Moxifloxacin (Avelox, BAY12-8039) + Levofloxacin & MetronidazoleBayerPhase 3
37
Dienogest (BAY86-5258, Visanne)BayerPre-clinical
23
Sevoflurane + propofol + remifentanilBaxterApproved
40